"The filmmaker stares down the world as it rolls forward, a chariot holding all we could be," writes Richard Newby in an ...

Gilead Sciences’ bid to extend the uses of TROP2-directed Trodelvy into lung cancer currently rests on the results of its EVOKE-01 study, revealed for the first time at this year’s ASCO.

"You're running against the guy whose values are antithetical to everything journalists represent ... I don't think we're ...